The story begins with student reports and advocacy group meetings rather than a public policy announcement. Members of the Montreal Trans Patient Union met with clinicians at McGill’s Student Wellness Hub and were told that some hormone replacement therapy requests from U.S. nationals under 19 had been refused. The group says the change stemmed from concerns tied to executive order 14187, issued by former President Trump in January 2026, and to a now‑amended online reporting tool hosted by the U.S. Department of Health and Human Services (HHS). In the meetings, advocates described the situation as covert and troubling for trans students on campus, and noted the practical reliance many international students have on campus health services. The TPU acronym is used by local activists to refer to the Montreal Trans Patient Union.
Those who raised alarms say the hub’s clinicians cited two main worries: the possibility of legal exposure and the difficulty medical staff might experience crossing the U.S. border. According to attendees, doctors mentioned legal guidance from the Canadian Medical Protective Association (CMPA) and the presence of a whistleblower mechanism on the HHS site that originally listed Canadian provinces in a drop-down menu. The HHS form was later corrected to list only U.S. states, but the inclusion of a “province” option had already alarmed some administrators. Advocates argue that American laws do not apply in Canada and call the denials inconsistent with Canadian medical ethics standards.
What advocates say happened at the Student Wellness Hub
Advocates who attended a March meeting with wellness hub staff report that clinicians confirmed at least two U.S. students under 19 were refused gender-affirming care. The clinic is the primary, timely route for many international students to obtain treatment because the university’s health plan channels non-resident students into on-campus services. For undergraduates who request care soon after arrival, the hub is often the most accessible option. Activists describe the hub’s approach as a new, unpublished practice that appeared after the academic year began, and they expect more students could face similar barriers if the informal restriction remains in place. The wellness hub provides a range of primary and specialized services to enrolled students.
Legal instruments and administrative pressures
HHS whistleblower form and cross-border confusion
A core administrative concern appears to have been the HHS online reporting tool associated with executive order 14187. That order aims to restrict certain care for minors within the United States, and HHS published a companion reporting mechanism inviting allegations of violations. The original form included an option to identify providers by “province” as well as “state,” which reportedly prompted anxiety among some Canadian clinicians and university administrators about being wrongfully targeted. Although the form was updated to remove the province option, its initial layout helped shape a precautionary response at McGill. Advocates view the chain of events as an example of how cross-border policy tools can generate unintended chilling effects.
CMPA guidance and McGill’s public position
Clinic staff reportedly sought and cited advice from the CMPA, the organization that offers legal protection and counsel to Canadian physicians. The CMPA maintains that its advice is confidential and that it does not set clinical policies, which leaves public accountability questions intact. McGill has issued statements affirming that access to gender-affirming care is available to students, including international students, and that clinical decisions are made by licensed physicians. Still, the university declined to confirm whether a policy exists that limits prescriptions to U.S. students under 19. Advocates say that lack of transparency undermines trust and runs counter to ethics rules stressing non‑discrimination by physicians.
Consequences for students and next steps
The practical impact is immediate for students who rely on the hub as their primary clinic: delays or denials of HRT can have significant physical and mental health consequences. Activists emphasize that hormones are medically indicated treatments that substantially improve wellbeing for many trans people and that arbitrary barriers raise ethical and legal concerns. The Quebec College of Physicians has suggested that refusing care on the basis of nationality would be a concerning scenario under professional codes. TPU members are calling for clearer institutional policy, public explanation from McGill, and confirmation that clinicians will follow Canadian standards rather than fear extraterritorial enforcement. The ethical duty referred to by regulators obliges physicians to provide or appropriately refer care regardless of a patient’s origin.